C07D 271/10
1,3,4-oxadiazoles
Official title: 1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
C07D271/10 (1,3,4-oxadiazoles) appears on 927 US grants and 861 published applications in this corpus.
Search patents in C07D- Granted patents
- 927
- Published applications
- 861
- Assignees
- 452
- Inventors
- 3,180
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 8 | 0 |
| 1978 | 16 | 0 |
| 1979 | 13 | 0 |
| 1980 | 11 | 0 |
| 1981 | 9 | 0 |
| 1982 | 5 | 0 |
| 1983 | 12 | 0 |
| 1984 | 9 | 0 |
| 1985 | 9 | 0 |
| 1986 | 7 | 0 |
| 1987 | 8 | 0 |
| 1988 | 6 | 0 |
| 1989 | 9 | 0 |
| 1990 | 11 | 0 |
| 1991 | 10 | 0 |
| 1992 | 12 | 0 |
| 1993 | 24 | 0 |
| 1994 | 17 | 0 |
| 1995 | 16 | 0 |
| 1996 | 15 | 0 |
| 1997 | 24 | 0 |
| 1998 | 14 | 0 |
| 1999 | 29 | 0 |
| 2000 | 28 | 0 |
| 2001 | 25 | 2 |
| 2002 | 12 | 21 |
| 2003 | 20 | 27 |
| 2004 | 11 | 33 |
| 2005 | 19 | 33 |
| 2006 | 13 | 40 |
| 2007 | 27 | 38 |
| 2008 | 18 | 31 |
| 2009 | 15 | 34 |
| 2010 | 25 | 37 |
| 2011 | 21 | 31 |
| 2012 | 22 | 34 |
| 2013 | 25 | 28 |
| 2014 | 27 | 45 |
| 2015 | 45 | 50 |
| 2016 | 32 | 35 |
| 2017 | 39 | 48 |
| 2018 | 32 | 42 |
| 2019 | 24 | 30 |
| 2020 | 28 | 40 |
| 2021 | 21 | 37 |
| 2022 | 22 | 27 |
| 2023 | 17 | 33 |
| 2024 | 30 | 44 |
| 2025 | 14 | 30 |
| 2026 | 11 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Use of silicon compounds in cyclization reactions21 Jul 2026US 12,686,662 B2Lanzhou Chemspec Technology Co., Ltd.
- Solid forms of a compound23 Jun 2026US 12,662,458 B2Denali Therapeutics Inc.
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications9 Jun 2026US 12,649,712 B2NucMito Pharmaceuticals Co. Ltd.
- Aryl formamide compound containing chiral sulfur oxide or salt thereof, preparation method, herbicidal composition and use thereof2 Jun 2026US 12,643,871 B2Qingdao Kingagroot Chemical Compound Co., Ltd.
- Oxadiazole derivative20 Aug 2026US 2026/0242345 A1Sumitomo Pharma Co., Ltd.
- Methods and compositions for treating hsd-1-mediated disorders30 Jul 2026US 2026/0217663 A1
- Compounds with immunomodulatory activity and therapeutic uses thereof30 Jul 2026US 2026/0217665 A1Purdue Research Foundation
- Method for producing 2-amino-5-substituted-1,3,4-oxadiazole23 Jul 2026US 2026/0209195 A1Mitsubishi Gas Chemical Next Company, Inc.
- Compound, pharmaceutical composition containing same, synthesis method therefor and use thereof16 Apr 2026US 2026/0103456 A1Shenzhen Zhongge Biological Technology Co., Ltd.
Most cited
By later US patents
- Spiro compounds and their use as electroluminescence materials179US 5,840,217 AHoechst Aktiengesellschaft · 1998
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- Poly(perfluoroalkylene oxide) derivatives106US 4,085,137 AMinnesota Mining and Manufacturing Company · 1978
- Modulators of ATP-binding cassette transporters106US 7,977,322 B2Vertex Pharmaceuticals Incorporated · 2011
- Poly(perfluoroalkylene oxide) derivatives104US 4,094,911 AMinnesota Mining and Manufacturing Company · 1978